Seminars in Hematology

Papers
(The H4-Index of Seminars in Hematology is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Special issue on chronic lymphocytic leukemia: Prognostication and therapeutic options introductory editorial158
CAR T-cell therapy comes of age: Introductory editorial for the special issue67
Clinical applications of circulating tumor DNA in Hodgkin lymphoma45
Insights from the 12th International Workshop on Waldenstrom's Macroglobulinemia37
Extramedullary myeloma in the era of CAR T-cell and bispecific antibody therapies37
Evolving insights into mitochondrial presence in RBC in sickle cell disease: Red blood cell and reticulocyte pathophysiology, therapeutic strategies, and future directions35
Updates on current and future research in acute myeloid leukemia32
How to set up a clinical research center in Brazil, as an example of a middle-income country28
The winding road: Infectious disease considerations for CAR-T and other novel adoptive cellular therapies in the era of COVID-1923
Lessons learned from the Eµ-TCL1 mouse model of CLL22
Epidemiology and etiology of diffuse large B-cell lymphoma22
The role of viruses in HIV-associated lymphomas21
Immune-driven clonal cell selection at the intersection among cancer, infections, autoimmunity and senescence21
The future of lymphoma diagnosis, prognosis, and treatment monitoring in countries with limited access to pathology services19
MRD-driven treatment strategies in CLL: Current practice, limitations, and emerging paradigms18
Antibody and immunotherapy in diffuse large B-cell lymphoma18
TET2 mutation as prototypic clonal hematopoiesis lesion18
More disease-modifying therapies for sickle cell disease: Are small molecules and drug repurposing the way forward?18
0.67334604263306